The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...
Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...
The Daily Galaxy on MSN
Japan approves the world’s first treatments made with reprogrammed human cells
Japan has cleared two therapies that began with the same lab technique and ended in very different parts of the body. One is ...
Morning Overview on MSN
Japan approves first treatment made from reprogrammed human cells
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...
CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of canc ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...
Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study. The findings ...
Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results